Lannett Co Inc (LCI) Receives Consensus Rating of “Hold” from Brokerages
Shares of Lannett Co Inc (NYSE:LCI) have received a consensus rating of “Hold” from the nine ratings firms that are covering the company, MarketBeat.com reports. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $21.00.
LCI has been the topic of several research analyst reports. Zacks Investment Research raised Lannett Co from a “sell” rating to a “hold” rating in a research note on Tuesday, July 11th. ValuEngine cut Lannett Co from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. BidaskClub cut Lannett Co from a “buy” rating to a “hold” rating in a research note on Monday, July 24th. BMO Capital Markets reissued a “market perform” rating and set a $20.00 target price (down from $26.00) on shares of Lannett Co in a research note on Thursday, August 24th. Finally, Deutsche Bank AG reissued a “hold” rating and set a $23.00 target price (up from $22.00) on shares of Lannett Co in a research note on Monday, July 17th.
Several institutional investors and hedge funds have recently bought and sold shares of the company. CS Mckee LP increased its stake in shares of Lannett Co by 0.6% during the second quarter. CS Mckee LP now owns 35,400 shares of the company’s stock valued at $722,000 after buying an additional 200 shares during the period. The Manufacturers Life Insurance Company increased its stake in shares of Lannett Co by 1.3% during the second quarter. The Manufacturers Life Insurance Company now owns 22,366 shares of the company’s stock valued at $456,000 after buying an additional 297 shares during the period. Royal Bank of Canada increased its stake in shares of Lannett Co by 10.6% during the second quarter. Royal Bank of Canada now owns 18,374 shares of the company’s stock valued at $374,000 after buying an additional 1,756 shares during the period. Tudor Investment Corp ET AL increased its stake in shares of Lannett Co by 70.2% during the second quarter. Tudor Investment Corp ET AL now owns 25,188 shares of the company’s stock valued at $514,000 after buying an additional 10,388 shares during the period. Finally, Voya Investment Management LLC increased its stake in shares of Lannett Co by 82.5% during the second quarter. Voya Investment Management LLC now owns 46,757 shares of the company’s stock valued at $954,000 after buying an additional 21,131 shares during the period. 87.92% of the stock is currently owned by hedge funds and other institutional investors.
Lannett Co (NYSE:LCI) traded down 0.95% during mid-day trading on Friday, reaching $20.90. 559,295 shares of the company’s stock were exchanged. The stock’s market cap is $779.24 million. Lannett Co has a one year low of $14.90 and a one year high of $27.90. The stock has a 50-day moving average of $18.29 and a 200-day moving average of $20.19.
Lannett Co (NYSE:LCI) last announced its quarterly earnings data on Wednesday, August 23rd. The company reported $0.40 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.40. Lannett Co had a positive return on equity of 19.80% and a negative net margin of 0.09%. The firm had revenue of $139.10 million during the quarter, compared to the consensus estimate of $139.01 million. During the same quarter in the previous year, the company posted $0.73 earnings per share. The business’s revenue was down 17.6% on a year-over-year basis. On average, equities research analysts anticipate that Lannett Co will post $2.60 earnings per share for the current year.
COPYRIGHT VIOLATION NOTICE: “Lannett Co Inc (LCI) Receives Consensus Rating of “Hold” from Brokerages” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this article on another publication, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/10/12/lannett-co-inc-lci-receives-consensus-rating-of-hold-from-brokerages.html.
About Lannett Co
Lannett Company, Inc develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company manufactures and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc As of June 30, 2016, the Company’s products included Acetazolamide Tablets; Butalbital, Acetaminophen and Caffeine Tablets; Butalbital, Aspirin and Caffeine Capsules; C-Topical Solution; Digoxin Tablets; Glycolax Rx; Isosorbide Mononitrate CR; Levothyroxine Sodium Tablets; Methylphenidate HCL CD; Methylphenidate ER; Nifedipine CR; Omeprazole DR; Oxbutynin ER; Pantoprazole DR; Pilocarpine HCl Tablets; Triamterene w/Hydrochlorothiazide Capsules, and Ursodiol Capsules.
Receive News & Stock Ratings for Lannett Co Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lannett Co Inc and related stocks with our FREE daily email newsletter.